Collplant
About:
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs.
Website: http://www.collplant.com
Twitter/X: CollplantBio
Top Investors: Meitav Investment House, Pontifax, Docor International Management, Meitav Underwriting, Modgal Industries
Description:
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also develops and commercializes tissue repair products for orthobiologics. The company's products are based on the rhCollagen that is produced with CollPlant’s proprietary plant-based genetic engineering technology. The rhCollagen BioInk is ideal for 3D bioprinting of tissues and organs, and the unique Vergenix line of rhCollagen products contains a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Rehovot, Israel.
$74.7M
$10M to $50M
Rehovot, HaMerkaz, Israel
1981-01-01
info(AT)collplant.com
51-100
2021-02-11
Public
© 2025 bioDAO.ai